Autopsy report · NCT01111188
Trial of PD 0332991 Plus Bortezomib in Patients With Relapsed Mantle Cell Lymphoma
Cause of deathNo reason given
Life of this trial
- Registered 4 months before it started.
- Ran for about 8 years 8 months before it stopped.
- 20 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Weill Medical College of Cornell University
- Sponsor type
- University, hospital or other
- Conditions
- Mantle Cell Lymphoma
- Interventions
- PD 0332991; bortezomib
- Participants
- 20
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.